Showing results (1061-1070 of 1,193) with videos related to
Sort By:
Pageof 120
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2021
Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid LeukemiaCourtney D DiNardo, Curtis A Lachowiez, Koichi Takahashi, et al.Cancer|June 14, 2017
TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimensRashmi Kanagal-Shamanna, Preetesh Jain, Koichi Takahashi, et al.Clinical Kidney Journal|October 29, 2014
Renal replacement therapy in Latin American end-stage renal diseaseGuillermo Rosa-Diez, Maria Gonzalez-Bedat, Roberto Pecoits-Filho, et al.American Journal of Hematology|March 15, 2020
Phase 2 study of hyper-CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemiaKoji Sasaki, Hagop Kantarjian, William Wierda, et al.Blood Cancer Journal|May 21, 2021
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cellsWarren Fiskus, Christopher P Mill, Behnam Nabet, et al.British Journal of Haematology|August 2, 2021
Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndromeKelly S Chien, Kunhwa Kim, Graciela M Nogueras-Gonzalez, et al.Journal of Hematology & Oncology|July 8, 2023
A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agentsNicholas J Short, Muharrem Muftuoglu, Faustine Ong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2023
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib StudyDavid A Sallman, Monzr M Al Malki, Adam S Asch, et al.Cancer|December 1, 2018
The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemiaPatrick Williams, Sreyashi Basu, Guillermo Garcia-Manero, et al.Kidney International Supplements|March 10, 2020
Global case studies for chronic kidney disease/end-stage kidney disease careChih-Wei Yang, David C H Harris, Valerie A Luyckx, et al.Pageof 120